Daniel Herranz

Rutgers Biomedical And Health Sciences

$3,591,285

Attributed

$3,591,285

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $585.7K · FY2015–25

$1M$750K$500K$250K$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,591,285 · 4

By mechanism

R01$2,502,573 · 2

R00$747,000 · 1

K99$341,712 · 1

Top collaborators

No co-investigators on record.

Most similar at Rutgers Biomedical And Health Sciences

Same institution · by research overlap

Shridar Ganesan$8,375,704
Yanxiang Guo$2,926,172
Zhiyuan Shen$13,804,956

Others in their field

Top investigators on “Signal Transduction”

Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
Garret A Fitzgerald · University Of Pennsylvania$66,142,222
Michael Barry Kastan · Duke University$64,512,357
Randall J Bateman · Washington University$62,939,456

Research focus

Signal TransductionAcute T Cell LeukemiaLeukemiaNotch1 GeneMediatingRefractoryGeneticIn VivoRelapseTherapeutic TargetMutationResistancePlayAutomobile DrivingChildChildhoodHematologic NeoplasmsClinical TrialsGamma SecretaseGenesOncogenesMapsMalignant NeoplasmsGenetic Transcription